America’s Bio and Pharma Manufacturing Renaissance: Where Do We Go From Here?
Join a discussion of best bio and pharma manufacturing practices, public policies and programs to help the US respond to the Covid-19 Pandemic and create a more resilient manufacturing infrastructure. Read more